Caricamento...
Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An Update
Ten mammalian diacylglycerol kinase (DGK) isozymes (α–κ) have been identified to date. Our previous review noted that several DGK isozymes can serve as potential drug targets for cancer, epilepsy, autoimmunity, cardiac hypertrophy, hypertension and type II diabetes (Sakane et al., 2008). Since then,...
Salvato in:
| Pubblicato in: | Front Cell Dev Biol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4987324/ https://ncbi.nlm.nih.gov/pubmed/27583247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2016.00082 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|